Table 5 OS analysis for patients with rectal cancer
Characteristics | Â | RMSTb (95%CI) | HRc (95%CI) | P valuea | Interaction p | |
|---|---|---|---|---|---|---|
Non-chemotherapy | Chemotherapy | |||||
Total | – | 53.7 (51.9–55.2) | 56.2 (55.2–57.0) | 0.539 (0.323–0.900) | 0.016 | – |
Sex | Male | 53.2 (50.7–55.1) | 55.9 (54.4–57.0) | 0.548 (0.298–1.006) | 0.048 | 0.931 |
Female | 54.5 (51.7–56.4) | 56.8 (54.8–58.0) | 0.534 (0.205–1.391) | 0.192 |  | |
Age (years) | ≤55 | 54.3 (48.0–57.6) | 56.3 (53.8–57.8) | 1.204 (0.264–5.499) | 0.810 | 0.314 |
56–60 | 55.4 (47.4–58.5) | 56.8 (54.4–58.2) | 0.698 (0.141–3.459) | 0.658 |  | |
61–65 | 53.3 (46.5–56.9) | 55.7 (52.9–57.5) | 0.490 (0.142–1.694) | 0.250 |  | |
66–70 | 53.2 (48.1–56.4) | 57.3 (53.6–58.8) | 0.605 (0.143–2.551) | 0.489 |  | |
> 70 | 53.6 (50.9–55.7) | 54.6 (49.5–57.1) | 0.568 (0.190–1.701) | 0.305 |  | |
Size (cm) | ≤5.0 | 54.0 (51.2–55.8) | 56.1 (54.5–57.2) | 0.510 (0.260–1.002) | 0.046 | 0.627 |
> 5.0 | 53.7 (50.5–55.8) | 56.3 (54.5–57.5) | 0.631 (0.280–1.422) | 0.261 |  | |
Differentiation | Well-moderate | 53.9 (52.0–55.4) | 56.3 (55.2–57.2) | 0.519 (0.305–0.883) | 0.014 | 0.309 |
Poor | 52.0 (43.2–56.6) | 54.7 (46.8–57.8) | 0.727 (0.102–5.208) | 0.750 |  | |
T category | 3 | 56.4 (53.7–58.0) | 57.6 (55.5–58.6) | 0.698 (0.253–1.925) | 0.484 | 0.350 |
4 | 51.8 (49.2–54.0) | 55.6 (54.2–56.8) | 0.431 (0.237–0.784) | 0.004 |  | |
CEAd (ng/mL) | < 5 | 54.6 (51.9–56.4) | 56.7 (55.3–57.8) | 0.568 (0.273–1.181) | 0.124 | 0.523 |
≥5 | 53.5 (50.1–55.7) | 55.1 (52.8–56.8) | 0.660 (0.273–1.598) | 0.354 |  | |
Examined lymph nodes | < 12 | 52.0 (47.5–54.9) | 53.6 (50.2–55.6) | 0.885 (0.375–2.091) | 0.780 | 0.169 |
≥12 | 54.5 (52.3–56.0) | 57.1 (55.9–57.9) | 0.401 (0.208–0.771) | 0.005 |  | |
PLRe | ≤130 | 56.0 (53.6–57.6) | 56.0 (54.3–57.2) | 0.898 (0.435–1.854) | 0.770 | 0.033 |
> 130 | 51.3 (47.8–53.7) | 56.5 (54.8–57.7) | 0.289 (0.131–0.638) | 0.001 |  | |